{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:40:05Z","timestamp":1781278805769,"version":"3.54.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,4,25]],"date-time":"2013-04-25T00:00:00Z","timestamp":1366848000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s12185-013-1348-2","type":"journal-article","created":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T11:20:42Z","timestamp":1367407242000},"page":"735-742","source":"Crossref","is-referenced-by-count":14,"title":["Treatment of gastric MALT lymphoma with a focus on Helicobacter pylori eradication"],"prefix":"10.1007","volume":"97","author":[{"given":"Qing","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanqi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,25]]},"reference":[{"key":"1348_CR1","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0140-6736(91)92035-Z","volume":"338","author":"AC Wotherspoon","year":"1991","unstructured":"Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991;338:1175\u20136.","journal-title":"Lancet"},{"key":"1348_CR2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0140-6736(93)91409-F","volume":"342","author":"AC Wotherspoon","year":"1993","unstructured":"Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993;342:575\u20137.","journal-title":"Lancet"},{"issue":"6","key":"1348_CR3","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/leu.2010.76","volume":"24","author":"VJ Craig","year":"2010","unstructured":"Craig VJ, Cogliatti SB, Arnold I, et al. B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis. Leukemia. 2010;24(6):1186\u201396.","journal-title":"Leukemia"},{"key":"1348_CR4","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4321\/S1130-01082007000700006","volume":"99","author":"LM Asenjo","year":"2007","unstructured":"Asenjo LM, Gisbert JP. Prevalence of Helicobacter pylori infection in gastric MALT lymphoma: a systematic review. Rev Esp Enferm Dig. 2007;99:398\u2013404.","journal-title":"Rev Esp Enferm Dig"},{"issue":"8972","key":"1348_CR5","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0140-6736(95)92823-5","volume":"346","author":"H Boot","year":"1995","unstructured":"Boot H, de Jong D, van Heerde P, Taal B. Role of Helicobacter pylori eradication in high-grade MALT lymphoma. Lancet. 1995;346(8972):448\u20139.","journal-title":"Lancet"},{"key":"1348_CR6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1477-7819-6-35","volume":"6","author":"L Cavanna","year":"2008","unstructured":"Cavanna L, Pagani R, Seghini P, et al. High grade B-cell gastric lymphoma with complete pathologic remission after eradication of Helicobacter pylori infection: report of a case and review of the literature. World J Surg Oncol. 2008;6:35.","journal-title":"World J Surg Oncol"},{"key":"1348_CR7","unstructured":"2012 NCCN guideline NCCN lymphoma guideline version 2.2012. Available from: http:\/\/www.nccn.org ."},{"key":"1348_CR8","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.dld.2007.05.016","volume":"39","author":"M Caselli","year":"2007","unstructured":"Caselli M, Zullo A, Maconi G, et al. \u201cCervia II Working Group Report 2006\u201d: guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy. Dig Liver Dis. 2007;39:782\u20139.","journal-title":"Dig Liver Dis"},{"key":"1348_CR9","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","volume":"56","author":"P Malfertheiner","year":"2007","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007;56:772\u201381.","journal-title":"Gut"},{"key":"1348_CR10","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1440-1746.2009.05982.x","volume":"24","author":"KM Fock","year":"2009","unstructured":"Fock KM, Katelaris P, Sugano K, et al. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol. 2009;24:1587\u2013600.","journal-title":"J Gastroenterol Hepatol"},{"key":"1348_CR11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ajg.2008.87","volume":"104","author":"T Rokkas","year":"2009","unstructured":"Rokkas T, Sechopoulos P, Robotis I, et al. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen. Am J Gastroenterol. 2009;104:21\u20135.","journal-title":"Am J Gastroenterol"},{"key":"1348_CR12","doi-asserted-by":"crossref","first-page":"962","DOI":"10.7326\/0003-4819-148-12-200806170-00227","volume":"148","author":"B Marshall","year":"2008","unstructured":"Marshall B. Sequential therapy for Helicobacter pylori: a worthwhile effort for your patients. Ann Intern Med. 2008;148:962\u20133.","journal-title":"Ann Intern Med"},{"key":"1348_CR13","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0140-6736(07)61455-X","volume":"370","author":"P Moayyedi","year":"2007","unstructured":"Moayyedi P. Sequential regimens for Helicobacter pylori eradication. Lancet. 2007;370:1010\u20132.","journal-title":"Lancet"},{"key":"1348_CR14","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gut.2007.125658","volume":"56","author":"A Zullo","year":"2007","unstructured":"Zullo A, De Francesco V, Hassan C, et al. The sequential therapy regimen for Helicobacter pylori eradication. Gut. 2007;56:1353\u20137.","journal-title":"Gut"},{"key":"1348_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-148-12-200806170-00226","volume":"148","author":"N Jafri","year":"2008","unstructured":"Jafri N, Hornung CA, Howden CW. Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment. Ann Intern Med. 2008;148:1\u201310.","journal-title":"Ann Intern Med"},{"key":"1348_CR16","first-page":"280","volume":"51","author":"WH Choi","year":"2008","unstructured":"Choi WH, Park DI, Oh SJ, et al. Effectiveness of 10\u00a0day-sequential therapy for Helicobacter pylori eradication in Korea. Korean J Gastroenterol. 2008;51:280\u20134.","journal-title":"Korean J Gastroenterol"},{"key":"1348_CR17","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/ajg.2009.314","volume":"104","author":"A Zullo","year":"2009","unstructured":"Zullo A, Hassan C, Andriani A, et al. Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis. Am J Gastroenterol. 2009;104:1932\u20137.","journal-title":"Am J Gastroenterol"},{"issue":"31","key":"1348_CR18","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1200\/JCO.2005.02.3903","volume":"23","author":"T W\u00fcndisch","year":"2005","unstructured":"W\u00fcndisch T, Thiede C, Morgner A, et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol. 2005;23(31):8018\u201324.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1348_CR19","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/annonc\/mdn760","volume":"20","author":"A Stathis","year":"2009","unstructured":"Stathis A, Chini C, Bertoni F, et al. Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. Ann Oncol. 2009;20(6):1086\u201393.","journal-title":"Ann Oncol"},{"key":"1348_CR20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cgh.2009.07.017","volume":"8","author":"A Zullo","year":"2010","unstructured":"Zullo A, Hassan C, Cristofari F, et al. Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol. 2010;8:105\u201310.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1348_CR21","doi-asserted-by":"crossref","unstructured":"Nakamura S, Sugiyama T, Matsumoto T, et al. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut. 2011 [Epub ahead of print].","DOI":"10.1136\/gutjnl-2011-300495"},{"key":"1348_CR22","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/gut.2005.083022","volume":"55","author":"M Raderer","year":"2006","unstructured":"Raderer M, Streubel B, Wohrer S, et al. Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas. Gut. 2006;55:616\u20138.","journal-title":"Gut"},{"key":"1348_CR23","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1002\/cncr.22326","volume":"107","author":"S Nakamura","year":"2006","unstructured":"Nakamura S, Matsumoto T, Ye H, et al. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment. Cancer. 2006;107:2770\u20138.","journal-title":"Cancer"},{"key":"1348_CR24","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3748\/wjg.v16.i17.2158","volume":"16","author":"HS Park","year":"2010","unstructured":"Park HS, Kim YJ, Yang WI, et al. Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma. World J Gastroenterol. 2010;16:2158\u201362.","journal-title":"World J Gastroenterol"},{"key":"1348_CR25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1442-200X.2010.03142.x","volume":"53","author":"SS Al Furaikh","year":"2011","unstructured":"Al Furaikh SS. Remission of high-grade B-cell lymphoma in a pediatric patient following Helicobacter pylori eradication. Pediatr Int. 2011;53:105\u20137.","journal-title":"Pediatr Int"},{"key":"1348_CR26","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/jnci\/89.18.1350","volume":"89","author":"A Neubauer","year":"1997","unstructured":"Neubauer A, Thiede C, Morgner A, et al. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst. 1997;89:1350\u20135.","journal-title":"J Natl Cancer Inst"},{"key":"1348_CR27","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(95)90113-2","volume":"345","author":"E Bayerdorffer","year":"1995","unstructured":"Bayerdorffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet. 1995;345:1591\u20134.","journal-title":"Lancet"},{"key":"1348_CR28","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/jnci\/dji277","volume":"97","author":"LT Chen","year":"2005","unstructured":"Chen LT, Lin JT, Tai JJ, et al. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J Natl Cancer Inst. 2005;97:1345\u201353.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"1348_CR29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s12185-008-0187-z","volume":"88","author":"G Dong","year":"2008","unstructured":"Dong G, Liu C, Ye H, et al. BCL10 nuclear expression and t(11;18)(q21;q21) indicate nonresponsiveness to Helicobacter pylori eradication of Chinese primary gastric MALT lymphoma. Int J Hematol. 2008;88(5):516\u201323.","journal-title":"Int J Hematol"},{"key":"1348_CR30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(00)03571-6","volume":"357","author":"H Liu","year":"2001","unstructured":"Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet. 2001;357:39\u201340.","journal-title":"Lancet"},{"issue":"1","key":"1348_CR31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.critrevonc.2007.01.003","volume":"63","author":"AJ Ferreri","year":"2007","unstructured":"Ferreri AJ, Montalban C. Primary diffuse large B-cell lymphoma of the stomach. Crit Rev Oncol Hematol. 2007;63(1):65\u201371.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1348_CR32","first-page":"1931","volume":"2011","author":"SR Owens","year":"2011","unstructured":"Owens SR, Smith LB. Molecular aspects of H. pylori-related malt lymphoma. Patholog Res Int. 2011;2011:1931\u201349.","journal-title":"Patholog Res Int"},{"key":"1348_CR33","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2036.2006.02827.x","volume":"23","author":"JP Gisbert","year":"2006","unstructured":"Gisbert JP, Luna M, Gomez B, et al. Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients. Aliment Pharmacol Ther. 2006;23:713\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"1348_CR34","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/j.1572-0241.2005.50043.x","volume":"100","author":"JP Gisbert","year":"2005","unstructured":"Gisbert JP. The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review. Am J Gastroenterol. 2005;100:2083\u201399.","journal-title":"Am J Gastroenterol"},{"key":"1348_CR35","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1136\/gut.2006.096420","volume":"56","author":"W Fischbach","year":"2007","unstructured":"Fischbach W, Goebeler ME, Ruskone-Fourmestraux A, et al. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Gut. 2007;56:1685\u20137.","journal-title":"Gut"},{"key":"1348_CR36","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1523-5378.2006.00460.x","volume":"11","author":"SS Hong","year":"2006","unstructured":"Hong SS, Jung HY, Choi KD, et al. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication. Helicobacter. 2006;11:569\u201373.","journal-title":"Helicobacter"},{"key":"1348_CR37","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.3748\/wjg.v13.i26.3554","volume":"13","author":"A Morgner","year":"2007","unstructured":"Morgner A, Schmelz R, Thiede C, et al. Therapy of gastric mucosa associated lymphoid tissue lymphoma. World J Gastroenterol. 2007;13:3554\u201366.","journal-title":"World J Gastroenterol"},{"key":"1348_CR38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5009\/gnl.2009.3.2.81","volume":"3","author":"H Suzuki","year":"2009","unstructured":"Suzuki H, Saito Y, Hibi T. Helicobacter pylori and gastric mucosa-associated lymphoid tissue (MALT) lymphoma: updated review of clinical outcomes and the molecular pathogenesis. Gut Liver. 2009;3:81\u20137.","journal-title":"Gut Liver"},{"issue":"16","key":"1348_CR39","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/cncr.25226","volume":"116","author":"JS Goda","year":"2010","unstructured":"Goda JS, Gospodarowicz M, Pintilie M, et al. Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy. Cancer. 2010;116(16):3815\u201324.","journal-title":"Cancer"},{"issue":"1","key":"1348_CR40","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijrobp.2009.04.018","volume":"77","author":"SH Son","year":"2010","unstructured":"Son SH, Choi BO, Kim GW, et al. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma). Int J Radiat Oncol Biol Phys. 2010;77(1):86\u201391.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1348_CR41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.radonc.2008.12.004","volume":"90","author":"N Tomita","year":"2009","unstructured":"Tomita N, Kodaira T, Tachibana H, et al. Favorable outcomes of radiotherapy for early-stage mucosa-associated lymphoid tissue lymphoma. Radiother Oncol. 2009;90(2):231\u20135.","journal-title":"Radiother Oncol"},{"issue":"3","key":"1348_CR42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2008.03.012","volume":"87","author":"H Yamashita","year":"2008","unstructured":"Yamashita H, Nakagawa K, Asari T, et al. Radiotherapy for 41 patients with stages I and II MALT lymphoma: a retrospective study. Radiother Oncol. 2008;87(3):412\u20137.","journal-title":"Radiother Oncol"},{"issue":"3","key":"1348_CR43","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/annonc\/mdn668","volume":"20","author":"PG Gobbi","year":"2009","unstructured":"Gobbi PG, Corbella F, Valentino F, et al. Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy. Ann Oncol. 2009;20(3):465\u20138.","journal-title":"Ann Oncol"},{"key":"1348_CR44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000339497","volume":"86","author":"H Okada","year":"2012","unstructured":"Okada H, Takemoto M, Kawahara Y, et al. A prospective analysis of efficacy and long-term outcome of radiation therapy for gastric mucosa-associated lymphoid tissue lymphoma. Digestion. 2012;86:179\u201386.","journal-title":"Digestion"},{"key":"1348_CR45","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1200\/JCO.1995.13.10.2524","volume":"13","author":"P Hammel","year":"1995","unstructured":"Hammel P, Haioun C, Chaumette MT, et al. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol. 1995;13:2524\u20139.","journal-title":"J Clin Oncol"},{"key":"1348_CR46","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1200\/JCO.2005.05.660","volume":"23","author":"M Levy","year":"2005","unstructured":"Levy M, Copie-Bergman C, Gameiro C, et al. Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy. J Clin Oncol. 2005;23:5061\u20136.","journal-title":"J Clin Oncol"},{"key":"1348_CR47","doi-asserted-by":"crossref","first-page":"19012","DOI":"10.1074\/jbc.M009984200","volume":"276","author":"PC Lucas","year":"2001","unstructured":"Lucas PC, Yonezumi M, Inohara N, et al. Bcl10 and MALT1, independent targets of chromosomal translocation in MALT-lymphoma, cooperate in a novel NF-\u00ceB signaling pathway. J Biol Chem. 2001;276:19012\u20139.","journal-title":"J Biol Chem"},{"issue":"6","key":"1348_CR48","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00280-011-1631-y","volume":"68","author":"SH Kuo","year":"2011","unstructured":"Kuo SH, Cheng AL, Lin CW, et al. t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement. Cancer Chemother Pharmacol. 2011;68(6):1387\u201395.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1348_CR49","doi-asserted-by":"crossref","unstructured":"Kiesewetter B, Troch M, Dolak W, et al. A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma). Haematologica. 2012 [Epub ahead of print].","DOI":"10.3324\/haematol.2012.065995"},{"key":"1348_CR50","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1200\/JCO.2002.05.117","volume":"20","author":"G J\u00e4ger","year":"2002","unstructured":"J\u00e4ger G, Neumeister P, Brezinschek R, et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. J Clin Oncol. 2002;20:3872\u20137.","journal-title":"J Clin Oncol"},{"key":"1348_CR51","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/annonc\/mdl126","volume":"17","author":"G Jager","year":"2006","unstructured":"Jager G, Neumeister P, Quehenberger F, et al. Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6\u00a0year follow-up of a phase II trial. Ann Oncol. 2006;17:1722\u20133.","journal-title":"Ann Oncol"},{"key":"1348_CR52","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1159\/000079502","volume":"66","author":"B Streubel","year":"2004","unstructured":"Streubel B, Ye H, Du MQ, et al. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma. Oncology. 2004;66:476\u201380.","journal-title":"Oncology"},{"key":"1348_CR53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1385\/MO:22:1:057","volume":"22","author":"A Aviles","year":"2005","unstructured":"Aviles A, Nambo MJ, Neri N, et al. Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial. Med Oncol. 2005;22:57\u201362.","journal-title":"Med Oncol"},{"key":"1348_CR54","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.1200\/JCO.2004.00.8532","volume":"23","author":"M Raderer","year":"2005","unstructured":"Raderer M, Wohrer S, Bartsch R, et al. Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma. J Clin Oncol. 2005;23:8442\u20136.","journal-title":"J Clin Oncol"},{"key":"1348_CR55","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000074641","volume":"65","author":"M Raderer","year":"2003","unstructured":"Raderer M, Jager G, Brugger S, et al. Rituximab for treatment of advanced extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue lymphoma. Oncology. 2003;65:306\u201310.","journal-title":"Oncology"},{"key":"1348_CR56","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","volume":"102","author":"A Conconi","year":"2003","unstructured":"Conconi A, Martinelli G, Thieblemont C, et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood. 2003;102:2741\u20135.","journal-title":"Blood"},{"key":"1348_CR57","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1200\/JCO.2005.08.128","volume":"23","author":"G Martinelli","year":"2005","unstructured":"Martinelli G, Laszlo D, Ferreri AJ, et al. Clinical activity of rituximab in gastric marginal zone non-Hodgkin\u2019s lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol. 2005;23:1979\u201383.","journal-title":"J Clin Oncol"},{"key":"1348_CR58","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/10428190903431820","volume":"51","author":"M Levy","year":"2010","unstructured":"Levy M, Copie-Bergman C, Molinier-Frenkel V, et al. Treatment of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: clinical, histological, and molecular follow-up. Leuk Lymphoma. 2010;51:284\u201390.","journal-title":"Leuk Lymphoma"},{"key":"1348_CR59","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1002\/cncr.24605","volume":"115","author":"A Salar","year":"2009","unstructured":"Salar A, Domingo-Domenech E, Estany C, et al. Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type. Cancer. 2009;115:5210\u20137.","journal-title":"Cancer"},{"issue":"5","key":"1348_CR60","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00277-011-1387-9","volume":"91","author":"M Troch","year":"2012","unstructured":"Troch M, Kiesewetter B, Dolak W, et al. Plasmacytic differentiation in MALT lymphomas following treatment with rituximab. Ann Hematol. 2012;91(5):723\u20138.","journal-title":"Ann Hematol"},{"key":"1348_CR61","doi-asserted-by":"crossref","unstructured":"Troch M, Kiesewetter B, Willenbacher W, et al. Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue-lymphoma: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie. Haematologica. 2012 [Epub ahead of print].","DOI":"10.3324\/haematol.2012.072587"},{"key":"1348_CR62","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1200\/JCO.2008.17.2015","volume":"26","author":"F Morschhauser","year":"2008","unstructured":"Morschhauser F, Radford J, Van Hoof A, et al. Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma. J Clin Oncol. 2008;26:5156\u201364.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1348_CR63","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/10428194.2010.534519","volume":"52","author":"M Hoffmann","year":"2011","unstructured":"Hoffmann M, Troch M, Eidherr H, et al. 90Y-ibritumomab tiuxetan (Zevalin) in heavily pretreated patients with mucosa associated lymphoid tissue lymphoma. Leuk Lymphoma. 2011;52(1):42\u20135.","journal-title":"Leuk Lymphoma"},{"key":"1348_CR64","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3332\/ecancer.2008.79","volume":"2","author":"P Ferrucci","year":"2008","unstructured":"Ferrucci P, Vanazzi A, Crosta C, et al. Efficacy of 90Y ibritumomab-tiuxetan treatment in a case of resistant gastric MALT non-Hodgkin\u2019s lymphoma. Ecancermedicalscience. 2008;2:79.","journal-title":"Ecancermedicalscience"},{"key":"1348_CR65","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1200\/JCO.2005.04.031","volume":"23","author":"P Koch","year":"2005","unstructured":"Koch P, Probst A, Berdel WE, et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02\/96). J Clin Oncol. 2005;23:7050\u20139.","journal-title":"J Clin Oncol"},{"key":"1348_CR66","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.radonc.2008.02.012","volume":"87","author":"C Vrieling","year":"2008","unstructured":"Vrieling C, de Jong D, Boot H, et al. Long-term results of stomach-conserving therapy in gastric MALT lymphoma. Radiother Oncol. 2008;87:405\u201311.","journal-title":"Radiother Oncol"},{"issue":"2","key":"1348_CR67","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12032-009-9207-y","volume":"27","author":"A Zullo","year":"2010","unstructured":"Zullo A, Hassan C, Andriani A, et al. Treatment of low-grade gastric MALT-lymphoma unresponsive to Helicobacter pylori therapy: a pooled-data analysis. Med Oncol. 2010;27(2):291\u20135.","journal-title":"Med Oncol"},{"key":"1348_CR68","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1016\/j.ejca.2008.07.005","volume":"44","author":"LG Capelle","year":"2008","unstructured":"Capelle LG, de Vries AC, Looman CW, et al. Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer. 2008;44:2470\u20136.","journal-title":"Eur J Cancer"},{"issue":"Suppl 4","key":"1348_CR69","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/annonc\/mdp146","volume":"20","author":"E Zucca","year":"2009","unstructured":"Zucca E, Dreyling M, ESMO Guidelines Working Group. Gastric marginal zone lymphoma of MALT type: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20(Suppl 4):113\u20134.","journal-title":"Ann Oncol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-013-1348-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-013-1348-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-013-1348-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T04:07:12Z","timestamp":1595736432000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-013-1348-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,25]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["1348"],"URL":"https:\/\/doi.org\/10.1007\/s12185-013-1348-2","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,25]]}}}